Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Current Issue

Volume 28,

Issue 12

15 June 2022

View This Issue

About the Journal

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics. Read More About the Journal

Editor-in-Chief

Keith T. Flaherty

View Full Editorial Board

Impact Factor

12.531

SUBMIT TO JOURNAL

Featured Articles

Clinical Trials: Targeted Therapy

ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients With ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges

Laura Q.M. Chow, et al.

CCR Translations

Predicting the Future: Machine-Based Learning for MRD Prognostication

Charlotte Pawlyn and Faith E. Davies

Clinical Trials: Immunotherapy

Pembrolizumab Monotherapy for Previously UntreatedAdvanced Hepatocellular Carcinoma: Data from theOpen-Label, Phase II KEYNOTE-224 Trial

Gontran Verset, et al.

Trending - Altmetric

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Last mentioned on Thursday June 23 2022

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

Last mentioned on Thursday June 23 2022

PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine

Last mentioned on Wednesday June 22 2022

Anti-cancer activity of the combination of cabozantinib and temozolomide in uterine sarcoma

Last mentioned on Wednesday June 22 2022

Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti–PD-1 Immune Checkpoint Blockade

Last mentioned on Thursday June 23 2022

Latest
Most Read
Most Cited

A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy

Tumor immune microenvironment changes by multiplex immunofluorescence staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a hereditary BRCA mutation

Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology directed repair (HDR) functional assay

Tweets by CCR_AACR

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept